Company news
SciBase Holding AB news in 2025
SciBase Holding AB's news releases, calls and decks from 2025, newest first.
The Board of Directors of SciBase resolves on a previously communicated rights issue of shares of approximately SEK 83 million
December 29, 2025
SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent
December 11, 2025
SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2
December 5, 2025
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)
December 5, 2025
The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million
November 7, 2025
SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million
November 7, 2025
Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2026
October 22, 2025
Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis
September 26, 2025
SciBase receives initial order for clinical study from Castle Biosciences
September 23, 2025
Main owners strengthen their position in SciBase
September 10, 2025
New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to Validating Nevisense
August 28, 2025
SciBase announces outcome in directed share issue
August 1, 2025
SciBase Launches Nevisense Pilot at Leading University in Southeast Florida
July 9, 2025
SciBase: A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense.
July 7, 2025
SciBase resolves on a directed share issue of approximately SEK 11 million
June 23, 2025
SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30
June 17, 2025
Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases
June 16, 2025
SciBase Initiates Self-Pay Model in the US to Make Nevisense Test More Accessible to Patients
June 9, 2025
SciBase Expands Further Through European Market with First Sales Order to customer in Italy
June 4, 2025
SciBase reaches milestone with over 300,000 patients tested with Nevisense
May 27, 2025